Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
In this Exclusive Interview, Dr. Robert Geho joins Diabetes in Control publisher Steve Freed at the 2016 Diabetes Symposium in Boston to discuss the testing, affects, and potential marketing of a new insulin delivery system currently undergoing trials.
Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc. In his role at Diasome, he leads the management and strategic direction of the Company’s targeted insulin therapies, novel type 2 diabetes technology, and oral therapy for obesity.
See the full interview below, or click here if you prefer to view the video broken into shorter segments.
A full transcript of the video is available here.